Long-term hematological response in a patient with 5q-syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy

被引:1
|
作者
Niscola, Pasquale [1 ]
Tendas, Andrea [1 ]
Scaramucci, Laura [1 ]
Merola, Roberta [2 ]
Catalano, Gianfranco [1 ]
de Fabritiis, Paolo [1 ]
机构
[1] S Eugenio Hosp, Hematol Unit, Rome, Italy
[2] Regina Elena Inst Canc Res, Cytogenet Unit, Dept Clin Pathol, Rome, Italy
关键词
D O I
10.5045/br.2014.49.2.130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:130 / 132
页数:3
相关论文
共 50 条
  • [41] The effect of long-term growth hormone therapy in a child with 18q deletion syndrome
    Pugliese, M
    Kay, S
    Davidoff-Feldman, B
    Hludzinski, J
    Sherman, J
    Blumberg, DL
    PEDIATRIC RESEARCH, 2000, 47 (04) : 138A - 138A
  • [42] Complete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!
    Al-Jafar, Hassan A.
    Al-Azmi, Salih
    Qassem, J. A.
    Hasan, Eman A.
    Alduaij, Arwa
    CASE REPORTS IN ONCOLOGY, 2012, 5 (03): : 586 - 591
  • [43] Successful autologous stem cell collection with filgrastim and plerixafor after long-term lenalidomide therapy for multiple myeloma
    Agarwal, Rishi
    Abidi, Muneer H.
    HEMATOLOGY REPORTS, 2012, 4 (04) : 98 - 100
  • [44] Long-term improvement of insulin sensitivity during CPAP therapy in the Obstructive Sleep Apnoea Syndrome
    Schahin, Simin Pour
    Nechanitzky, Thomas
    Dittel, Christian
    Fuchs, Florian S.
    Hahn, Eckhart G.
    Konturek, Peter C.
    Ficker, Joachim H.
    Harsch, Igor A.
    MEDICAL SCIENCE MONITOR, 2008, 14 (03): : CR117 - CR121
  • [45] Durability of histological and biochemical improvement after stopping pioglitazone therapy for nonalcoholic steatothepatitis (NASH). Is long-term therapy needed?
    Lutchman, G
    Promrat, K
    Kleiner, DE
    Ghany, M
    Heller, T
    Borg, B
    Park, Y
    Liang, TJ
    Hoofnagle, JH
    GASTROENTEROLOGY, 2005, 128 (04) : A695 - A695
  • [46] Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy
    E. Leo
    A. Krämer
    A. Hochhaus
    F. Krasniqi
    R. Hehlmann
    A. Ho
    Annals of Hematology, 2002, 81 : 467 - 469
  • [47] Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome
    Tsurumi, Hanako
    Fujigaki, Yoshihide
    Yamamoto, Tadashi
    Iino, Risa
    Taniguchi, Kei
    Nagura, Michito
    Arai, Shigeyuki
    Tamura, Yoshifuru
    Ota, Tatsuru
    Shibata, Shigeru
    Kondo, Fukuo
    Kurose, Nozomu
    Masaki, Yasufumi
    Uchida, Shunya
    INTERNAL MEDICINE, 2018, 57 (10) : 1433 - 1438
  • [48] Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy
    Leo, E
    Krämer, A
    Hochhaus, A
    Krasniqi, F
    Hehlmann, R
    Ho, AD
    ANNALS OF HEMATOLOGY, 2002, 81 (08) : 467 - 469
  • [49] Long-term outcomes after fetal therapy for congenital high airway obstructive syndrome
    Saadai, Payam
    Jelin, Eric B.
    Nijagal, Amar
    Schecter, Samuel C.
    Hirose, Shinjiro
    MacKenzie, Tippi C.
    Rand, Larry
    Goldstein, Ruth
    Farrell, Jody
    Harrison, Michael
    Lee, Hanmin
    JOURNAL OF PEDIATRIC SURGERY, 2012, 47 (06) : 1095 - 1100
  • [50] MEIGE SYNDROME (BLEPHAROSPASM-OROMANDIBULAR DYSTONIA) AFTER LONG-TERM NEUROLEPTIC THERAPY
    WEINER, WJ
    NAUSIEDA, PA
    GLANTZ, RH
    NEUROLOGY, 1981, 31 (12) : 1555 - 1556